A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma
Authors
Keywords
Mesothelioma, Prolonged infusion, Gemcitabine, Cisplatin
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 73, Issue 5, Pages 975-982
Publisher
Springer Nature
Online
2014-04-01
DOI
10.1007/s00280-014-2429-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy
- (2013) Francesco Grossi et al. LUNG CANCER
- First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial
- (2012) Ó Arrieta et al. BRITISH JOURNAL OF CANCER
- Health-related quality of life in patients with lung cancer: Validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire
- (2012) Óscar Arrieta et al. LUNG CANCER
- A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
- (2011) Viljem Kovac et al. ANTI-CANCER DRUGS
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
- (2011) Vanya Delgermaa et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Global Magnitude of Reported and Unreported Mesothelioma
- (2011) Eun-Kee Park et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
- (2011) Tom Treasure et al. LANCET ONCOLOGY
- Chemotherapy and targeted therapies for unresectable malignant mesothelioma
- (2011) Ronan Joseph Kelly et al. LUNG CANCER
- Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
- (2011) Beth Woods et al. LUNG CANCER
- Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II Clinical Trial
- (2010) Matjaz Zwitter et al. Journal of Thoracic Oncology
- Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma
- (2009) Marc de Perrot et al. JOURNAL OF CLINICAL ONCOLOGY
- Malignant Pleural Mesothelioma
- (2009) Anne S. Tsao et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
- (2008) J B Sørensen et al. BRITISH JOURNAL OF CANCER
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients
- (2008) Raja M. Flores et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: A review of practice in British Columbia
- (2008) Christopher W. Lee et al. LUNG CANCER
- Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
- (2007) Sujith R. Kalmadi et al. LUNG CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started